High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma

Overview of attention for article published in Acta Neuropathologica Communications, July 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

twitter: 8 X users

Citations

dimensions_citation: 49 Dimensions

Readers on

mendeley: 69 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 49 publications that cite this research output.

49

The most recent citing publications are shown below. View all 49 publications that cite this research output on Dimensions.

Ependymoma from Benign to Highly Aggressive Diseases: A Review

Book chapter (April 2024)

Ependymomas of the spinal region in adults: Clinical and pathological features and MYCN expression levels in spinal ependymomas and myxopapillary ependymomas

Article in Annals of Diagnostic Pathology (March 2024)

Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?

Article in Frontiers in Molecular Neuroscience (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.